Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-6615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
filingDate |
2004-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2007514725-A |
titleOfInvention |
Immunostimulatory composition comprising at least one Toll-like receptor 7 or Toll-like receptor 8 agonist and Toll-like receptor 4 agonist |
abstract |
The present invention relates to an immunostimulatory composition comprising at least one Toll-like receptor 7 or Toll-like receptor 8 agonist and Toll-like receptor 4 agonist. The composition of the present invention may also comprise a vaccine antigen. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10842848-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590179-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008539249-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10537626-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11491204-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016163489-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11304997-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10875900-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016163489-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759518-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291718-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526388-B2 |
priorityDate |
2003-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |